Thyroid tumors with preoperative recurrent laryngeal nerve palsy: Clinicopathologic features and treatment outcome

被引:31
作者
Chiang, Feng-Yu
Lin, Jen-Chih
Lee, Ka-Wo
Wang, Ling-Feng
Tsai, Kuo-Bow
Wu, Che-Wei
Lu, Shang-Pin
Kuo, Wen-Rei
机构
[1] Kaohsiung Med Univ Hosp, Dept Otolaryngol, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Otolaryngol, Fac Med, Coll Med, Kaohsiung 807, Taiwan
[3] Kaohsiung Med Univ, Dept Pathol, Fac Med, Coll Med, Kaohsiung 807, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Otolaryngol, Kaohsiung 807, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Pathol, Kaohsiung 807, Taiwan
[6] Penghu Hosp, Dept Hlth, Kaohsiung 807, Taiwan
关键词
D O I
10.1016/j.surg.2006.02.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The aim of this present study is to define the significance of recurrent laryngeal nerve palsy (RLNP) detected before surgery for thyroid diseases with regard to the incidence of malignancy, histopathologic distribution, extrathyroidal invasion, management, and prognosis. Methods. Six hundred and twenty-two patients underwent operation for various thyroid disease and were treated by the same surgeon. The study was confined to 16 (3%) patients who suffered from a thyroid tumor with preoperative RLNP. Results. Of these 16 patients, 1 had benign thyroid disease, while the other 15 had malignancy (94%). Among the 15 cancer patients, 14 had extrathyroidal invasion and needed more extensive surgical procedures than total thyroidectomy. The recurrent laryngeal nerve could be dissected from the thyroid neoplasm in 3 patients, 2 of whom experienced recovery of this nerve's function Postoperatively. Conclusions. Thyroid tumor associated with RLATP is strongly suggestive of malignancy. The RLN should be preserved if it has not been invaded by the tumor because it offers a good chance of functional recovery Postoperatively. Well-differentiated thyroid cancer accounts for only half of these patients who tend to present at an older age and feature a much higher incidence of upper aerodigestive tract invasion. The operations for these Patients often are complex and should be performed by experienced surgeons. Radical excision of a resectable anaplastic or squamous cell carcinoma of the thyroid gland offers the chance, albeit small, of long-term survival in this study.
引用
收藏
页码:413 / 417
页数:5
相关论文
共 35 条
  • [1] Management of thyroid carcinoma invading the aerodigestive tract
    Bayles, SW
    Kingdom, TT
    Carlson, GW
    [J]. LARYNGOSCOPE, 1998, 108 (09) : 1402 - 1407
  • [2] Recurrent laryngeal nerve palsy in well-differentiated thyroid carcinoma: Clinicopathologic features and outcome study
    Chan, WF
    Lo, CY
    Lam, KY
    Wan, KY
    [J]. WORLD JOURNAL OF SURGERY, 2004, 28 (11) : 1093 - 1098
  • [3] Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve
    Chiang, FY
    Wang, LF
    Huang, YF
    Lee, KW
    Kuo, WR
    [J]. SURGERY, 2005, 137 (03) : 342 - 347
  • [4] RELATIONSHIP BETWEEN VOCAL CORD PARALYSIS AND BENIGN THYROID-DISEASE
    COLLAZOCLAVELL, ML
    GHARIB, H
    MARAGOS, NE
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (01): : 24 - 30
  • [5] Squamous cell carcinoma of the thyroid: outcome of treatment in 16 patients
    Cook, AM
    Vini, L
    Harmer, C
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (06): : 606 - 609
  • [6] MANAGEMENT OF THE RECURRENT LARYNGEAL NERVE IN SUSPECTED AND PROVEN THYROID-CANCER
    FALK, SA
    MCCAFFREY, TV
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 113 (01) : 42 - 48
  • [7] STATISTICAL-ANALYSIS OF MALIGNANT-TUMORS DETECTED AS THE CAUSE OF VOCAL CORD PARALYSIS
    FURUKAWA, M
    FURUKAWA, MK
    OOISHI, K
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1994, 56 (03): : 161 - 165
  • [8] Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO
  • [9] 2-0
  • [10] Haigh PI, 2001, CANCER-AM CANCER SOC, V91, P2335, DOI 10.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.3.CO